, Volume 68, Issue 4, pp 565–577 | Cite as

Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro

  • Aleksandra GornostaevaEmail author
  • Elena Andreeva
  • Ludmila Buravkova


Multipotent mesenchymal stem/stromal cells (MSCs) are of great interest to researchers because of the unique properties, such as enhanced proliferation, paracrine activity and multilineage differentiation. Their non-immunogenicity, in combination with immunomodulatory properties, opens up the opportunity for the allogeneic application of MSCs. The MSC immunomodulatory capacity is currently being actively studied in vitro using various experimental designs. However, the results are not always univocal. It was found that the outcome of the stromal/immune cell interaction depends on experimental conditions. In this review we considered the impact of different factors, such as the ratio of stromal/immune cells, interaction time, the path of immune cell activation, etc. on the MSC immunomodulation. We also accentuated the importance of local milieu, in particular, oxygen tension, for the realization of MSC immunosuppressive activity.


MSCs Lymphocytes Activation Low oxygen Cell-to-cell interaction Immunosuppression 



This study was funded by Grant RFBR 13-04-00791, Grant RFBR 14-04-31362 mol_a and grant of the President of the Russian Federation SP-3502.2015.4.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822CrossRefGoogle Scholar
  2. Andreeva ER, Grigorieva OV, Andrianova IV, Gornostaeva AN, Buravkova LB (2012) Human stromal and blood-born cells interaction under different O2 tension. part I. Immunocupressive effects. Technol Living Syst 9:13–18Google Scholar
  3. Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32:252–260CrossRefGoogle Scholar
  4. Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42–48CrossRefGoogle Scholar
  5. Benvenuto F, Ferrari S, Gerdoni E et al (2007) Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25:1753–1760CrossRefGoogle Scholar
  6. Buravkova LB, Grinakovskaia OS, Andreeva EP, Zhambalova AP, Kozionova MP (2009) Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension. Tsitologiia 51:5–11Google Scholar
  7. Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318–324CrossRefGoogle Scholar
  8. Cappellesso-Fleury S, Puissant B, Apoil PA et al (2010) Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 30:607–619CrossRefGoogle Scholar
  9. Carrade Holt DD, Wood JA, Granick JL et al (2014) Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. Stem Cells Dev 23:1258–1265CrossRefGoogle Scholar
  10. Chabannes D, Hill M, Merieau E et al (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110:3691–3694CrossRefGoogle Scholar
  11. Corcione A, Benvenuto F, Ferretti E et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367–372CrossRefGoogle Scholar
  12. Crop M, Baan CC, Korevaar SS et al (2010) Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19:1843–1853CrossRefGoogle Scholar
  13. Deng W, Han Q, Liao L et al (2005) Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24:458–463CrossRefGoogle Scholar
  14. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8:315–317CrossRefGoogle Scholar
  15. Engela AU, Baan CC, Dor Frank JMF et al (2012) On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol 3:126–134CrossRefGoogle Scholar
  16. Fehrer C, Brunauer R, Laschober G et al (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745–757CrossRefGoogle Scholar
  17. Francois M, Romieu-Mourez R, Li M, Galipeau J (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20:187–195CrossRefGoogle Scholar
  18. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403Google Scholar
  19. Glennie S, Soeiro I, Dyson PJ et al (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821–2827CrossRefGoogle Scholar
  20. Gornostaeva AN, Andreeva ER, Andrianova IV, Buravkova LB (2011) Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium. Bull Exp Biol Med 151:526–529CrossRefGoogle Scholar
  21. Gornostaeva AN, Andreeva ER, Buravkova LB (2013) Human MMSC immunosuppressive activity at low oxygen tension: direct cell-to-cell contacts and paracrine regulation. Hum Physiol 39:31–42CrossRefGoogle Scholar
  22. Grayson WL, Zhao F, Bunnell B, Ma T (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358:948–953CrossRefGoogle Scholar
  23. Grigoryan AS, Tsupkina NV, Sergeev VS et al (2007) Characterization of bone marrow stromal cells in the mixed lymphocyte reaction. Cell Transplantol Tissue Eng 2:62–66Google Scholar
  24. Groh ME, Maitra B, Szekely E, Koc ON (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33:928–934CrossRefGoogle Scholar
  25. Huang XP, Sun Z, Miyagi Y et al (2010) Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122:2419–2429CrossRefGoogle Scholar
  26. Ja Friedenstein A, Luria EA (1980) Cellular bases of hemopoietic microenviroment. Meditsina, MoscowGoogle Scholar
  27. Jarvinen L, Badri L, Wettlaufer S et al (2008) Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol. 181:4389–4396CrossRefGoogle Scholar
  28. Jiang XX, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120–4126CrossRefGoogle Scholar
  29. Jones BJ, McTaggart J (2008) Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 36:733–741CrossRefGoogle Scholar
  30. Kim JH, Lee YT, Hong JM, Hwang YI (2013) Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression. Anat Cell Biol 46:262–271CrossRefGoogle Scholar
  31. Kim DS, Lee MW, Yoo KH et al (2014) gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density. PLoS One 9:e83363. doi: 10.1371/journal.pone.0083363 CrossRefGoogle Scholar
  32. Krampera M, Cosmi L, Angeli R et al (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386–398CrossRefGoogle Scholar
  33. Kronsteiner B, Wolbank S, Peterbauer A et al (2011) Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 20:2115–2126CrossRefGoogle Scholar
  34. Le Blanc K, Tammik C, Rosendahl K et al (2003a) b) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890–896CrossRefGoogle Scholar
  35. Le Blanc K, Tammik L, Sundberg B et al (2003b) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11–20CrossRefGoogle Scholar
  36. Le Blanc K, Rasmusson I, Gotherstrom C et al (2004) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60:307–315CrossRefGoogle Scholar
  37. Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586CrossRefGoogle Scholar
  38. Lee MW, Kim DS, Ryu S et al (2013) Effect of ex vivo culture conditions on immunosuppression by human mesenchymal stem cells. Biomed Res Int 2013:154919. doi: 10.1155/2013/154919 Google Scholar
  39. Lin CS, Lin G, Lue TF (2012) Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev 12:2770–2778CrossRefGoogle Scholar
  40. Maccario R, Podesta M, Moretta A et al (2005) Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Stem Cell Transplant Haematol 90:516–525Google Scholar
  41. Mcintosh K, Zvonic S, Garrett S et al (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246–1253CrossRefGoogle Scholar
  42. Meisel R, Zibert A, Laryea M et al (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation. Blood 103:4619–4621CrossRefGoogle Scholar
  43. Nauta AJ, Kruisselbrink AB, Lurvink E et al (2006) Mesenchymal stem cells inhibit generation and function of both CD34-derived and monocyte-derived dendritic cells. J Immunol 177:2080–2087CrossRefGoogle Scholar
  44. Nekanti U, Dastidar S, Venugopal P et al (2010) Increased proliferation and analysis of differential gene expression in human wharton’s jelly-derived mesenchymal stromal cells under hypoxia. Cell 6:499–512Google Scholar
  45. Niemeyer P, Vohrer J, Schmal H et al (2008) Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 10:784–795CrossRefGoogle Scholar
  46. Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132:631–644CrossRefGoogle Scholar
  47. Park MJ, Shin JS, Kim YH et al (2011) Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α (CD25) cleavage by producing matrix metalloproteinases. Stem Cell Rev 7:381–393CrossRefGoogle Scholar
  48. Pigotta JH, Ishiharaa A, Wellmanb ML et al (2013) Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Vet Immunol Immunopathol 156:99–106CrossRefGoogle Scholar
  49. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-Inflammatory cytokines, IFNγ and TNFa, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially. PLoS One 5:e9016CrossRefGoogle Scholar
  50. Puissant B, Barreau C, Bourin P et al (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118–129CrossRefGoogle Scholar
  51. Quaedackers ME, Baan CC, Weimar W, Hoogduijn MJ (2009) Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes. Eur J Immunol 39:3436–3446CrossRefGoogle Scholar
  52. Ramasamy R, Tong CK, Seow HF et al (2008) The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T-cell proliferation but not its effector function. Cell Immunol 251:131–136CrossRefGoogle Scholar
  53. Ren G, Su J, Zhang L et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954–1962CrossRefGoogle Scholar
  54. Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353–363CrossRefGoogle Scholar
  55. Saldanha-Araujo F, Haddad R, Kelen CR et al (2012) Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-kB signaling. J Cell Mol Med 16:1232–1244CrossRefGoogle Scholar
  56. Selmani Z, Naji A, Zidi I et al (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress t lymphocyte and natural killer function and to induce CD4-CD25 high FOXP3- regulatory T cells. Stem Cells 26:212–222CrossRefGoogle Scholar
  57. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136–143CrossRefGoogle Scholar
  58. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74–85CrossRefGoogle Scholar
  59. Spaggiari GM, Capobianco A, Becchetti S et al (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484–1490CrossRefGoogle Scholar
  60. Suva D, Passweg J, Arnaudeau S et al (2008) In vitro activated human t lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. J Cell Physiol 214:588–594CrossRefGoogle Scholar
  61. Tasso R, Ilengo C, Quarto R et al (2012) Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 53:786–793CrossRefGoogle Scholar
  62. Yang SH, Park MJ, Yoon IH et al (2009) Soluble mediators from mesenchymal stem cells supress T cell proliferation by inducing IL-10. Exp Mol Med 41:315–324CrossRefGoogle Scholar
  63. Zappia E, Casazza S, Pedemonte E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755–1761CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Aleksandra Gornostaeva
    • 1
    Email author
  • Elena Andreeva
    • 1
  • Ludmila Buravkova
    • 1
  1. 1.Institute of Biomedical Problems of RASMoscowRussia

Personalised recommendations